Equine Influenza Vaccine Market
Equine Influenza Vaccine Market Size, Share and Trend Analysis Report, By Vaccine Type (Powder and Liquid), By End-Users (Home, Pet Clinic, and Others), Forecast Period (2026-2035)
Industry Overview
Global equine influenza vaccine market was valued at $58.9 million in 2025 and is projected to reach $111.7 million by 2035, growing at a CAGR of 6.6% from 2026 to 2035. The global market is experiencing steady expansion, supported by increasing emphasis on preventive healthcare practices and rising awareness of disease management in animal populations. Growing investments in veterinary healthcare infrastructure and advancements in vaccine development technologies are further contributing to market progression. In addition, the expansion of organized equine facilities and competitive events has led to greater adoption of routine immunization programs. Regulatory frameworks in several regions are also encouraging vaccination to control disease outbreaks. Furthermore, improved distribution networks and accessibility of veterinary products are enhancing market penetration. Collectively, these factors are reinforcing sustained growth across the market.
Market Dynamics
Rising Adoption of Preventive Vaccination Programs
The global market is witnessing a significant shift toward preventive healthcare, with equine owners and veterinary practices increasingly prioritizing routine immunization. This trend is driven by the recognition of the economic and health benefits of early disease prevention. Advancements in vaccine formulations and administration methods have made preventive care more effective and accessible. Simultaneously, awareness campaigns by veterinary associations are educating stakeholders about the importance of timely vaccination. As a result, regular immunization schedules are becoming standard practice across many regions. This widespread adoption is directly contributing to the consistent expansion of the market.
Expansion of Veterinary Infrastructure and Distribution Networks
Improved veterinary healthcare infrastructure and enhanced distribution channels are shaping the growth trajectory of the global market. The establishment of modern clinics, mobile veterinary services, and specialized equine health centers has increased access to vaccines. Strengthened supply chains ensure the timely delivery of high-quality vaccines to remote and urban areas alike. Additionally, collaborations between manufacturers and regional distributors are expanding the reach of commercial products. This enhanced availability is facilitating broader adoption of vaccination programs. Overall, infrastructure and distribution advancements are playing a critical role in sustaining market growth.
Market Segmentation
- Based on the vaccine type, the market is segmented into powder and liquid.
- Based on the end-users, the market is segmented into home, pet clinic, and others.
Liquid Segment to Lead the Market with the Largest Share
The liquid vaccine segment is witnessing robust growth due to its ease of administration and faster immunogenic response in equines. Enhanced formulation technologies have improved stability and efficacy, making liquid vaccines the preferred choice among veterinarians and large equine facilities. Key players such as Zoetis Inc., Boehringer Ingelheim, and Merck & Co., Inc. are actively expanding their liquid vaccine portfolios to cater to rising demand. Recent trends include the development of multi-strain formulations and combination vaccines that provide broader protection. Distribution channels are also being strengthened to ensure timely availability in both urban and rural regions. Collectively, these factors are driving steady adoption and market expansion for liquid vaccines.
Pet Clinics: A Key Segment in Market Growth
Pet clinics are emerging as a key driver of market growth by providing accessible and professional vaccination services for equine populations. Clinics are increasingly offering structured immunization programs, encouraging routine vaccinations and preventive healthcare practices. Major industry players, including Ceva Santé Animale and Virbac S.A., are collaborating with clinics to enhance product availability and support veterinary guidance. Recent developments show a rise in clinic-based campaigns and educational initiatives to improve owner compliance. The convenience of professional administration and monitoring further boosts the segment’s appeal. Consequently, the pet clinic sub-segment is experiencing sustained expansion across major markets.
Regional Outlook
The global equine influenza vaccine market is further divided by geography, including North America (the US and Canada), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), and the Rest of the World (the Middle East & Africa, and Latin America).
North America Region Dominates the Market with Major Share
North America remains a dominant region in the global equine influenza vaccine market due to its well-established veterinary infrastructure and widespread awareness of preventive healthcare. High equine population density, combined with organized equestrian events, drives consistent demand for vaccination programs. Key players such as Zoetis Inc., Merck & Co., Inc., and Boehringer Ingelheim maintain a strong presence through extensive distribution networks and clinic partnerships. Recent trends include the introduction of advanced multi-strain vaccines and enhanced cold-chain logistics for better product stability. Educational initiatives by veterinary associations are further supporting routine immunization. These factors collectively reinforce the region’s sustained market leadership.
Asia-Pacific to Witness as a Fastest Growing Region
The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing equine ownership, rising investments in veterinary healthcare, and growing awareness of equine disease prevention. Regional manufacturers and global players, including Ceva Santé Animale and Virbac S.A., are actively expanding their distribution and marketing efforts to tap into new markets. Recent trends highlight the launch of cost-effective vaccines and mobile veterinary services to reach remote areas. Government initiatives and equestrian sports development are also contributing to adoption. Improved supply chain infrastructure ensures better accessibility of vaccines across urban and rural zones. These dynamics position Asia-Pacific for accelerated growth in the coming years.
Market Players Outlook
The major companies operating in the global equine influenza vaccine market include Zoetis Inc., Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Inc., and Ceva Santé Animale, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global equine influenza vaccine market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Global Equine Influenza Vaccine Market Sales Analysis – Vaccine Type | End-Users ($ Million)
- Equine Influenza Vaccine Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Equine Influenza Vaccine Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Equine Influenza Vaccine Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For Global Equine Influenza Vaccine Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Global Equine Influenza Vaccine Market: Impact Analysis
- Market Opportunities
- Opportunities For Global Equine Influenza Vaccine Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Equine Influenza Vaccine Market Revenue and Share by Manufacturers
- Equine Influenza Vaccine Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Boehringer Ingelheim International GmbH
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Ceva Santé Animale
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Elanco Animal Health Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Merck & Co., Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Zoetis Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Boehringer Ingelheim International GmbH
- Key Company Analysis
- Global Equine Influenza Vaccine Market Sales Analysis by Vaccine Type ($ Million)
- Powder
- Liquid
- Global Equine Influenza Vaccine Market Sales Analysis by End-Users ($ Million)
- Home
- Pet Clinic
- Others
- Regional Analysis
- North American Equine Influenza Vaccine Market Sales Analysis – Vaccine Type | End-Users | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Equine Influenza Vaccine Market Sales Analysis – Vaccine Type | End-Users | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Equine Influenza Vaccine Market Sales Analysis – Vaccine Type | End-Users | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Others)
- Rest of Asia-Pacific
- Rest of the World Equine Influenza Vaccine Market Sales Analysis – Vaccine Type | End-Users | Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Bayer Animal Health
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bimeda Holdings PLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Biogénesis Bagó
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bioveta, a.s.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Boehringer Ingelheim International GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ceva Santé Animale
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Colorado Serum Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Elanco Animal Health Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Heska Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Hester Biosciences Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- HIPRA S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- IDT Biologika GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Indian Immunologicals Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Lohmann Animal Health
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merck & Co., Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Merial Animal Health Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Neogen Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Phibro Animal Health Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Ringpu (Tianjin) Bio?Pharmacy Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vaccine Solutions GmbH
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vetoquinol S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Virbac S.A.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zoetis Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bayer Animal Health
1. Global Equine Influenza Vaccine Market Research And Analysis By Vaccine Type, 2025-2035 ($ Million)
2. Global Equine Influenza Vaccine in Powder Market Research And Analysis By Region, 2025-2035 ($ Million)
3. Global Equine Influenza Vaccine in Liquid Market Research And Analysis By Region, 2025-2035 ($ Million)
4. Global Equine Influenza Vaccine Market Research And Analysis By End-Users, 2025-2035 ($ Million)
5. Global Equine Influenza Vaccine For Home Market Research And Analysis By Region, 2025-2035 ($ Million)
6. Global Equine Influenza Vaccine For Pet Clinic Market Research And Analysis By Region, 2025-2035 ($ Million)
7. Global Equine Influenza Vaccine For Others Market Research And Analysis By Region, 2025-2035 ($ Million)
8. Global Equine Influenza Vaccine Market Research And Analysis By Geography, 2025-2035 ($ Million)
9. North American Equine Influenza Vaccine Market Research And Analysis By Country, 2025-2035 ($ Million)
10. North American Equine Influenza Vaccine Market Research And Analysis By Vaccine Type, 2025-2035 ($ Million)
11. North American Equine Influenza Vaccine Market Research And Analysis By End-Users, 2025-2035 ($ Million)
12. European Equine Influenza Vaccine Market Research And Analysis By Country, 2025-2035 ($ Million)
13. European Equine Influenza Vaccine Market Research And Analysis By Vaccine Type, 2025-2035 ($ Million)
14. European Equine Influenza Vaccine Market Research And Analysis By End-Users, 2025-2035 ($ Million)
15. Asia-Pacific Equine Influenza Vaccine Market Research And Analysis By Country, 2025-2035 ($ Million)
16. Asia-Pacific Equine Influenza Vaccine Market Research And Analysis By Vaccine Type, 2025-2035 ($ Million)
17. Asia-Pacific Equine Influenza Vaccine Market Research And Analysis By End-Users, 2025-2035 ($ Million)
18. Rest Of The World Equine Influenza Vaccine Market Research And Analysis By Country, 2025-2035 ($ Million)
19. Rest Of The World Equine Influenza Vaccine Market Research And Analysis By Vaccine Type, 2025-2035 ($ Million)
20. Rest Of The World Equine Influenza Vaccine Market Research And Analysis By End-Users, 2025-2035 ($ Million)
1. Global Equine Influenza Vaccine Market Share By Vaccine Type, 2025 Vs 2035 (%)
2. Global Equine Influenza Vaccine in Powder Market Share By Region, 2025 Vs 2035 (%)
3. Global Equine Influenza Vaccine in Liquid Market Share By Region, 2025 Vs 2035 (%)
4. Global Equine Influenza Vaccine Market Share By End-Users, 2025 Vs 2035 (%)
5. Global Equine Influenza Vaccine For Home Market Share By Region, 2025 Vs 2035 (%)
6. Global Equine Influenza Vaccine For Pet Clinic Market Share By Region, 2025 Vs 2035 (%)
7. Global Equine Influenza Vaccine For Others Market Share By Region, 2025 Vs 2035 (%)
8. Global Equine Influenza Vaccine Market Share By Region, 2025 Vs 2035 (%)
9. US Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
10. Canada Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
11. UK Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
12. France Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
13. Germany Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
14. Italy Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
15. Spain Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
16. Russia Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
17. Rest Of Europe Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
18. India Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
19. China Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
20. Japan Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
21. South Korea Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
22. ASEAN Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
23. Australia and New Zealand Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
24. Rest Of Asia-Pacific Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
25. Latin America Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
26. Middle East And Africa Equine Influenza Vaccine Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
